Science Explorer Back to mapMap

Most cited papers in Hemophilia Treatment and Research

What are the most cited papers in Hemophilia Treatment and Research?

The most cited paper in Hemophilia Treatment and Research is "Mutation in blood coagulation factor V associated with resistance to activated protein C" (Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al., 1994), with 3,854 citations. Next come "Hematological Problems in Pediatric Intensive Care" (3,516) and "WFH Guidelines for the Management of Hemophilia, 3rd edition" (2,029).

Showing 50 of 99 papers. Every paper with more than 534 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mutation in blood coagulation factor V associated with resistance to activated protein C Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature May 1994 3,854
2 Hematological Problems in Pediatric Intensive Care Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille et al. · Pediatric and adolescent medicine Book chapter 28 Nov 2013 3,516
3 WFH Guidelines for the Management of Hemophilia, 3rd edition Alok Srivastava, Elena Santagostino, Alison Dougall et al. · Haemophilia Open access Aug 2020 2,029
4 Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences Open access Feb 1993 1,990
5 Guidelines for the management of hemophilia Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten et al. · Haemophilia Open access 6 Jul 2012 1,938
6 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 10 Nov 2022 1,921
7 Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B Amit C. Nathwani et al. · New England Journal of Medicine Open access 10 Dec 2011 1,875
8 The coagulation cascade: initiation, maintenance, and regulation Earl W. Davie, Kazuo Fujikawa, Walter Kisiel · Biochemistry Oct 1991 1,823
9 Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection Eric Lawitz et al. · New England Journal of Medicine 23 Apr 2013 1,794
10 A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Joan M. Bathon, Richard W. Martin, Roy Fleischmann et al. · New England Journal of Medicine Open access 30 Nov 2000 1,752
11 The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital Matthew A. Borgman, Philip Charles Spinella, Jeremy G. Perkins et al. · The Journal of Trauma: Injury, Infection, and Critical Care Oct 2007 1,590
12 A Cell-based Model of Hemostasis Dougald M. Monroe, Maureane Hoffman · Thrombosis and Haemostasis 2001 1,542
13 Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty Bengt I. Eriksson, Lars C. Borris, Richard Joel Friedman et al. · New England Journal of Medicine Open access 25 Jun 2008 1,440
14 BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR J. Evan Sadler · Annual Review of Biochemistry ReviewOpen access Jun 1998 1,378
15 Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection Nezam H. Afdhal et al. · New England Journal of Medicine 12 Apr 2014 1,312
16 Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells ERIC A. JAFFE, Leon W. Hoyer, Ralph L. Nachman · Journal of Clinical Investigation Open access Nov 1973 1,292
17 Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B Amit Chunilal Nathwani et al. · New England Journal of Medicine Open access 20 Nov 2014 1,276
18 Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine Open access 14 May 2008 1,265
19 The molecular basis of blood coagulation Bruce Furie, Barbara C. Furie · Cell May 1988 1,254
20 Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Thomas A. Drake, James H. Morrissey, Thomas S. Edgington · PubMed Open access May 1989 1,199
21 Development of the human coagulation system in the full-term infant M Andrew, Bosco A Paes, RUTH A. MILNER et al. · Blood Open access Jul 1987 1,190
22 Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine Open access 23 Feb 2005 1,172
23 World distribution of factor V Leiden David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet Oct 1995 1,170
24 Resistance to Activated Protein C as a Basis for Venous Thrombosis Peter J. Svensson, Björn Dahlbäck · New England Journal of Medicine Open access 24 Feb 1994 1,130
25 Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion C. A. Llewelyn, P. B Hewitt, RSG Knight et al. · The Lancet Feb 2004 1,130
26 Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura Joel L. Moake, Christine K. Rudy, Joseph H. Troll et al. · New England Journal of Medicine 2 Dec 1982 1,119
27 Emicizumab Prophylaxis in Hemophilia A with Inhibitors Johannes Oldenburg, Johnny Ndoni Mahlangu, Benjamin B. Kim et al. · New England Journal of Medicine Open access 10 Jul 2017 1,117
28 The Hemophilias — From Royal Genes to Gene Therapy Pier Mannuccio Mannucci, Edward G. D. Tuddenham · New England Journal of Medicine 7 Jun 2001 1,101
29 Cochrane Injuries Group Albumin ReviewersWhy albumin may not work Abi Berger · BMJ Open access 25 Jul 1998 1,089
30 Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men Paul M. Ridker, Charles H. Hennekens, Klaus Lindpaintner et al. · New England Journal of Medicine Open access 6 Apr 1995 1,057
31 Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero R. Cataland, Flora Peyvandi et al. · New England Journal of Medicine Open access 9 Jan 2019 1,038
32 Characterization of the human factor VIII gene Jane Gitschier, William I. Wood, Therese M. Goralka et al. · Nature Nov 1984 1,001
33 The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor Deficiencies Robert R. Proctor, Samuel I. Rapaport · American Journal of Clinical Pathology Sep 1961 998
34 Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B I. M. Nilsson, Erik E. Berntorp, Thomas Löfqvist et al. · Journal of Internal Medicine Jul 1992 971
35 Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man Haig H. Kazazian, Corinne Kung Yen Wong, Hagop Youssoufian et al. · Nature Mar 1988 946
36 Molecular cloning of a cDNA encoding human antihaemophilic factor John J. Toole, John L. Knopf, John M. Wozney et al. · Nature Nov 1984 942
37 Maturation of the hemostatic system during childhood M Andrew, Patricia Vegh, Marilyn Johnston et al. · Blood Open access 15 Oct 1992 909
38 Structure of human factor VIII Gordon A. Vehar, Bruce A. Keyt, Dan Eaton et al. · Nature Nov 1984 899
39 Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter et al. · The Lancet Feb 2008 872
40 Surface-dependent reactions of the vitamin K-dependent enzyme complexes KG Mann, ME Nesheim, W R Church et al. · Blood Jul 1990 861
41 Acquired von Willebrand Syndrome in Aortic Stenosis André Vincentelli, Sophie Susen, Thierry Le Tourneau et al. · New England Journal of Medicine Open access 23 Jul 2003 852
42 An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences Scott C. Kogan, Marie Doherty, Jane Gitschier · New England Journal of Medicine 15 Oct 1987 806
43 Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A Delia Lakich, Haig H. Kazazian, Stylianos E. Antonarakis et al. · Nature Genetics Open access Nov 1993 802
44 Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials Kenneth David Boffard, Bruno Riou, Brian Warren et al. · The Journal of Trauma: Injury, Infection, and Critical Care Jul 2005 786
45 Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant Lindsey A. George et al. · New England Journal of Medicine Open access 6 Dec 2017 774
46 High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism Paul Alexander Kyrle, Erich Minar, Mirko Hirschl et al. · New England Journal of Medicine Open access 17 Aug 2000 770
47 Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors Johnny Ndoni Mahlangu, Johannes Oldenburg, Ido Paz‐Priel et al. · New England Journal of Medicine Open access 29 Aug 2018 769
48 Haemophilias A and B Paula H. B. Bolton‐Maggs, John Pasi · The Lancet May 2003 764
49 Definitions in hemophilia: communication from the SSC of the ISTH Victor S. Blanchette, Nigel S. Key, L.R. Ljung et al. · Journal of Thrombosis and Haemostasis Open access 24 Jul 2014 763
50 Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course Konrad Bork, Gabriele Meng, Petra Staubach et al. · The American Journal of Medicine Open access 21 Feb 2006 759

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.